<?xml version="1.0" encoding="UTF-8"?>
<p>Six new 4a-
 <italic>epi</italic>-plicamine-type alkaloids, named zephygranditines A–C (
 <bold>18</bold>–
 <bold>20</bold>, 
 <xref ref-type="fig" rid="molecules-25-05621-f002">Figure 2</xref> and 
 <xref rid="molecules-25-05621-t001" ref-type="table">Table 1</xref> and 
 <xref rid="molecules-25-05621-t002" ref-type="table">Table 2</xref>) and zephygranditines D–F (
 <bold>21</bold>–
 <bold>23</bold>, 
 <xref ref-type="fig" rid="molecules-25-05621-f002">Figure 2</xref>, 
 <xref rid="molecules-25-05621-t001" ref-type="table">Table 1</xref>), including three novel 11,12-seco-plicamine-type alkaloids, were isolated from the organic extract of 
 <italic>Z. grandiflora.</italic> Zephygranditines A–C (
 <bold>18</bold>–
 <bold>20</bold>) alkaloids showed cytotoxic activity against seven malignant melanoma cell lines with IC
 <sub>50</sub> values &lt; 20 μM, while only alkaloids 
 <bold>18</bold> and 
 <bold>19</bold> exhibited anti-inflammatory activity in both assays of inhibitory activity for nitric oxide production and Cox-1/Cox-2 [
 <xref rid="B56-molecules-25-05621" ref-type="bibr">56</xref>].
</p>
